First Blood-Based Test Cleared For Alzheimer’s Boosts Anti-Amyloid Drugs

Early Diagnosis Key To Treating Mild Cognitive Impairment

 
• By Mandy Jackson
  
Anti-amyloid drug prescribers can now diagnose Alzheimer's pathology with a blood test rather than a PET scan or CSF test (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Scrip